Accolade (NASDAQ:ACCD – Get Free Report) is set to issue its quarterly earnings data before the market opens on Tuesday, October 8th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Accolade Price Performance
NASDAQ:ACCD opened at $3.85 on Tuesday. Accolade has a one year low of $3.35 and a one year high of $15.36. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.80 and a current ratio of 2.80. The firm has a market cap of $308.03 million, a price-to-earnings ratio of -3.32 and a beta of 2.00. The firm’s fifty day moving average is $4.03 and its two-hundred day moving average is $6.08.
Analyst Upgrades and Downgrades
ACCD has been the topic of several recent research reports. Guggenheim lowered their price target on shares of Accolade from $13.00 to $6.00 and set a “buy” rating on the stock in a report on Friday, June 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $13.00 price target on shares of Accolade in a report on Monday, June 24th. Morgan Stanley lowered their price target on shares of Accolade from $12.00 to $6.00 and set an “equal weight” rating on the stock in a report on Friday, June 28th. Barclays lowered their price target on shares of Accolade from $11.00 to $5.50 and set an “equal weight” rating on the stock in a report on Friday, June 28th. Finally, Stifel Nicolaus decreased their price objective on shares of Accolade from $13.00 to $8.00 and set a “buy” rating for the company in a research report on Friday, June 28th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Accolade presently has an average rating of “Moderate Buy” and an average target price of $11.65.
About Accolade
Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians.
Featured Articles
- Five stocks we like better than Accolade
- Why Are Stock Sectors Important to Successful Investing?
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What is the NASDAQ Stock Exchange?
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Canada Bond Market Holiday: How to Invest and Trade
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.